Risto Härkönen

1.4k total citations
23 papers, 1.0k citations indexed

About

Risto Härkönen is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Risto Härkönen has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 11 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Risto Härkönen's work include Cardiac Imaging and Diagnostics (8 papers), Cardiovascular Function and Risk Factors (7 papers) and Advanced MRI Techniques and Applications (7 papers). Risto Härkönen is often cited by papers focused on Cardiac Imaging and Diagnostics (8 papers), Cardiovascular Function and Risk Factors (7 papers) and Advanced MRI Techniques and Applications (7 papers). Risto Härkönen collaborates with scholars based in Finland, United Kingdom and Japan. Risto Härkönen's co-authors include Juhani Knuuti, Pirjo Nuutila, Merja Haaparanta‐Solin, Ulla Ruotsalainen, U Wegelius, Jorma Viikari, Matti Luotolahti, Maija Mäki, Hidehiro Iida and Markku Saraste and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes.

In The Last Decade

Risto Härkönen

22 papers receiving 997 citations

Peers

Risto Härkönen

CCM

RNMI

EDM

SURGE

H. Frenzel Germany

Bunyad Haider United States

Matti Luotolahti Finland

S. Sultan Ahmed United States

Zhi You Fang Australia

Teemu Takala Finland

B. Saurbier Germany

Michihito Sekiya Japan

Khalid Abozguia United Kingdom

Chinori Kurata Japan

H. Frenzel Germany

Risto Härkönen

664 ×1.2

CCM

372 ×0.7

RNMI

79 ×0.4

EDM

213 ×1.2

SURGE

200 ×1.6

Citations per year, relative to Risto Härkönen Risto Härkönen (= 1×) peers H. Frenzel

Countries citing papers authored by Risto Härkönen

Since Specialization

Citations

This map shows the geographic impact of Risto Härkönen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Risto Härkönen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Risto Härkönen more than expected).

Fields of papers citing papers by Risto Härkönen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Risto Härkönen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Risto Härkönen. The network helps show where Risto Härkönen may publish in the future.

Co-authorship network of co-authors of Risto Härkönen

This figure shows the co-authorship network connecting the top 25 collaborators of Risto Härkönen. A scholar is included among the top collaborators of Risto Härkönen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Risto Härkönen. Risto Härkönen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jahnukainen, Timo, Kerttu Irjala, Risto Härkönen, et al.. (2008). Comparison of glomerular function tests in children with cancer. Pediatric Nephrology. 23(5). 797–803. 23 indexed citations

Läutamaki, Riikka, Juhani Airaksinen, Marko Seppänen, et al.. (2006). Insulin Improves Myocardial Blood Flow in Patients With Type 2 Diabetes and Coronary Artery Disease. Diabetes. 55(2). 511–516. 70 indexed citations

Läutamaki, Riikka, Juhani Airaksinen, Marko Seppänen, et al.. (2005). Rosiglitazone Improves Myocardial Glucose Uptake in Patients With Type 2 Diabetes and Coronary Artery Disease. Diabetes. 54(9). 2787–2794. 83 indexed citations

Bergström, Kim, Risto Härkönen, Kalevi Kairemo, et al.. (2000). The development of nuclear medicine in Finland: a review on the occasion of the 40th anniversary of the Finnish Society of Nuclear Medicine. Clinical Physiology. 20(5). 317–329.

Lamusuo, Salla, Hanna Ruottinen, Juhani Knuuti, et al.. (1997). Comparison of[18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex. Journal of Neurology Neurosurgery & Psychiatry. 63(6). 743–748. 20 indexed citations

Raitakari, Olli T., Harri Niinikoski, Pirjo Nuutila, et al.. (1996). Coronary Flow Reserve Is Impaired in Young Men With Familial Hypercholesterolemia. Journal of the American College of Cardiology. 28(7). 1705–1711. 131 indexed citations

Mäki, Maija, Matti Luotolahti, Pirjo Nuutila, et al.. (1996). Glucose Uptake in the Chronically Dysfunctional but Viable Myocardium. Circulation. 93(9). 1658–1666. 118 indexed citations

Knuuti, Juhani, Maija Mäki, Hannele Yki‐Järvinen, et al.. (1995). The Effect of Insulin and FFA on Myocardial Glucose Uptake. Journal of Molecular and Cellular Cardiology. 27(7). 1359–1367. 56 indexed citations

Knuuti, Juhani, Markku Saraste, Pirjo Nuutila, et al.. (1994). Myocardial viability: Fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. American Heart Journal. 127(4). 785–796. 63 indexed citations

10.

Knuuti, Juhani, H Yki-Järvinen, L M Voipio-Pulkki, et al.. (1994). Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.. PubMed. 35(6). 989–98. 65 indexed citations

11.

Parto, Katriina, et al.. (1993). Pulmonary Manifestations in Lysinuric Protein Intolerance. CHEST Journal. 104(4). 1176–1182. 55 indexed citations

12.

Knuuti, Juhani, Pirjo Nuutila, Ulla Ruotsalainen, et al.. (1993). The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET.. PubMed. 34(12). 2068–75. 50 indexed citations

13.

Knuuti, Juhani, Ingela Wiklund, Paul A. Smith, et al.. (1992). Acute and long-term effects on myocardial ischemia of intermittent and continuous transdermal nitrate therapy in stable angina. The American Journal of Cardiology. 69(19). 1525–1532. 15 indexed citations

14.

Kuusi, T, Christian Ehnholm, Jorma Viikari, et al.. (1989). Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia.. Journal of Lipid Research. 30(8). 1117–1126. 120 indexed citations

15.

Luurila, O, et al.. (1989). Carvedilol and atenolol once daily in the treatment of hypertension. Journal of Hypertension. 7(6). S264–265. 1 indexed citations

16.

Rehnqvist, Nina, Gunnar Olsson, Jan Engvall, et al.. (1988). Abrupt withdrawal of isosorbide-5-mononitrate in Durules® (Imdur®) after long term treatment in patients with stable angina pectoris. European Heart Journal. 9(12). 1339–1347. 10 indexed citations

17.

Uusitalo, Arto, O Keyriläinen, Risto Härkönen, et al.. (1988). Anti‐anginal Efficacy of a Controlled‐Release Formulation of lsosorbide‐5‐mononitrate Once Daily in Angina Patients on Chronic β‐Blockade. Acta Medica Scandinavica. 223(3). 219–225. 8 indexed citations

18.

Luurila, O, Pentti Gröhn, Juhani Heikkilä, et al.. (1987). Exercise capacity and hemodynamics in persons aged 20 to 50 years with systemic hypertension treated with diltiazem and atenolol. The American Journal of Cardiology. 60(10). 832–835. 8 indexed citations

19.

Uusitalo, Arto, et al.. (1986). Metoprolol, nifedipine, and the combination in stable effort angina pectoris. The American Journal of Cardiology. 57(10). 733–737. 44 indexed citations

20.

Alanko, Kristiina, et al.. (1983). Combination of fenoterol and ipratropium bromide in the treatment of bronchial asthma.. PubMed. 128 (Pt 2). 546–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact